Literature DB >> 9112919

Comparison of three operations for typhoid perforation.

E A Ameh1, P M Dogo, M M Attah, P T Nmadu.   

Abstract

BACKGROUND: Typhoid fever is a public health problem in the developing world and gut perforation remains the major complication with a high associated mortality rate. Even though most surgeons agree that elimination of peritoneal soilage and endotoxaemia by surgery offers the best hope of survival, the extent of surgery remains controversial. This prospective study compared the results of three operations for this condition.
METHODS: A total of 64 patients with clinical suspicion of typhoid perforation were treated by one of three operations (simple closure, wedge excision and anastomosis or segmental resection and anastomosis) at this hospital. The management protocol was the same for the three groups. The risk of reperforation, mortality rate and duration of hospital stay were compared.
RESULTS: The risk of reperforation and mortality rate were highest (two and 13 of 21 respectively) in patients who had wedge excision and lowest (zero and nine of 25 respectively) in those who had segmental resection. The risk of reperforation and mortality rate were zero and nine of 18 respectively in the simple closure group.
CONCLUSION: Segmental resection seems to be the best treatment for typhoid perforation and is recommended for surgeons practising in a similar environment.

Entities:  

Mesh:

Year:  1997        PMID: 9112919

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  13 in total

Review 1.  Current Trends in the Management of Typhoid Fever.

Authors:  S P Kalra; N Naithani; S R Mehta; A J Swamy
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Typhoid colonic perforation in childhood: a ten-year experience.

Authors:  Yu-Tang Chang; Jan-You Lin; Yu-Sheng Huang
Journal:  World J Surg       Date:  2006-02       Impact factor: 3.352

3.  Predictor of mortality in children with typhoid intestinal perforation in a Tertiary Hospital in Nigeria.

Authors:  Abdulrasheed A Nasir; Lukman O Abdur-Rahman; James O Adeniran
Journal:  Pediatr Surg Int       Date:  2011-05-19       Impact factor: 1.827

4.  Typhoid intestinal perforation in children: a continuing scourge in a developing country.

Authors:  Aba F Uba; Lohfa B Chirdan; Akpabio M Ituen; Aminu M Mohammed
Journal:  Pediatr Surg Int       Date:  2006-11-04       Impact factor: 1.827

5.  Non-traumatic perforation of the small bowel.

Authors:  Hani O Eid; Ashraf F Hefny; Sandhya Joshi; Fikri M Abu-Zidan
Journal:  Afr Health Sci       Date:  2008-03       Impact factor: 0.927

6.  Predictors of mortality in children with typhoid ileal perforation in a Nigerian tertiary hospital.

Authors:  Ademola Olusegun Talabi; Amarachukwu Chiduziem Etonyeaku; Oludayo Adedapo Sowande; Samuel Anu Olowookere; Olusanya Adejuyigbe
Journal:  Pediatr Surg Int       Date:  2014-10-04       Impact factor: 1.827

7.  Typhoid intestinal perforations: twenty-six year experience.

Authors:  S Selcuk Atamanalp; Bulent Aydinli; Gurkan Ozturk; Durkaya Oren; Mahmut Basoglu; M Ilhan Yildirgan
Journal:  World J Surg       Date:  2007-09       Impact factor: 3.352

8.  Nontraumatic terminal ileal perforation.

Authors:  Rauf A Wani; Fazl Q Parray; Nadeem A Bhat; Mehmood A Wani; Tasaduq H Bhat; Fowzia Farzana
Journal:  World J Emerg Surg       Date:  2006-03-24       Impact factor: 5.469

9.  Risk adjustment is crucial in comparing outcomes of various surgical modalities in patients with ileal perforation.

Authors:  Ravindra Singh Mohil; Tanveer Singh; Satyavrat Arya; Dinesh Bhatnagar
Journal:  Patient Saf Surg       Date:  2008-11-24

10.  Comparative analysis of primary repair vs resection and anastomosis, with laparostomy, in management of typhoid intestinal perforation: results of a rural hospital in northwestern Benin.

Authors:  Roberto Caronna; Alassan Kadiri Boukari; Dieudonnè Zaongo; Thierry Hessou; Rènè Castro Gayito; Cesar Ahononga; Sosten Adeniran; Giambattista Priuli
Journal:  BMC Gastroenterol       Date:  2013-06-19       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.